000			01779 a2200493 4500
005			20250514041843.0
264		0	_c20030306
008			200303s 0 0 eng d
022			_a0041-1345
024	7		_a10.1016/s0041-1345(02)02894-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aEbbs, A
245	0	0	_aTacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration. _h[electronic resource]
260			_bTransplantation proceedings _cAug 2002
300			_a1378-81 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aCD4-Positive T-Lymphocytes _ximmunology
650	0	4	_aCD8-Positive T-Lymphocytes _ximmunology
650	0	4	_aCyclosporine _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aGraft Rejection _xprevention & control
650	0	4	_aGranzymes
650	0	4	_aHeart Transplantation _ximmunology
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInterleukin-10 _xantagonists & inhibitors
650	0	4	_aMembrane Glycoproteins _xanalysis
650	0	4	_aPerforin
650	0	4	_aPore Forming Cytotoxic Proteins
650	0	4	_aRats
650	0	4	_aRats, Inbred BN
650	0	4	_aRats, Inbred Lew
650	0	4	_aSerine Endopeptidases _xanalysis
650	0	4	_aTacrolimus _xtherapeutic use
650	0	4	_aTransplantation, Homologous _ximmunology
650	0	4	_aTransplantation, Isogeneic _ximmunology
700	1		_aPan, F
700	1		_aWynn, C
700	1		_aErickson, L
700	1		_aKobayashi, M
700	1		_aJiang, H
773	0		_tTransplantation proceedings _gvol. 34 _gno. 5 _gp. 1378-81
856	4	0	_uhttps://doi.org/10.1016/s0041-1345(02)02894-4 _zAvailable from publisher's website
999			_c12059010 _d12059010